Latest Thrombosis Stories
Researchers from the University of North Carolina at Chapel Hill reduced damage from a heart attack by 50 percent by enhancing a protective protein found in mice and humans.
Scientists modified a protein in the heart which dramatically reduced cell damage after heart attacks.
According to court documents, on February 15th, 2012, North Dakota resident Donna L. Praus filed a lawsuit (case no.
Patients who are receiving chemotherapy for cancer are at risk for venous thromboembolism. Now, researchers show how a new treatment may help.
For decades, the blood thinner heparin has been used to prevent and treat blood clots.
A researcher at Intermountain Medical Center in Salt Lake City is part of a select panel of international experts to help develop new evidence-based clinical guidelines used by physicians worldwide for the diagnosis and treatment of blood-clotting disorders, one of the most common cardiovascular diseases in the United States.
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.